Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections. - Burm R; Maravelia P; Ahlen G; Ciesek S; Caro Perez N; Pasetto A; Urban S; Van Houtte F; Verhoye L; Wedemeyer H; Johansson M; Frelin L; et al. (Gut, 2023)